癌症中的CHD1失调:弥合染色质不稳定性,治疗耐药性和免疫逃避
K S Praveen Kumar1, M N Jyothi2, Akila Prashant3
1Department of Medical Genetics, JSS Medical College and Hospital, JSS-AHER, 570015, Mysuru, India, Karnataka. praveenkumarks@jssuni.edu.in.
Molecular biology reports
|April 25, 2025
概括
染色体-酶-DNA结合蛋白1 (CHD1) 对于基因表达和DNA修复至关重要. 它在癌症,特别是前列腺癌中的复杂作用提供了潜在的治疗点,尽管需要进一步的研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 染色体-酶-DNA结合蛋白1 (CHD1) 是染色体结构和基因表达的关键调节者.
- CHD1在DNA修复和保持基因组稳定性方面发挥着重要作用.
- 人类各种癌症中越来越多地认识到CHD1的失调.
研究的目的:
- 批判性地审查CHD1在癌症生物学中的多方面的作用.
- 要突出CHD1的上下文依赖的功能,特别是在前列腺癌.
- 确定CHD1作为治疗点的知识差距和未来研究方向.
主要方法:
- 在癌症中研究CHD1的研究的文献综述.
- 分析CHD1在基因表达,DNA修复和染色质动态中的功能.
- 关于CHD1在不同癌症类型和治疗耐药性中的作用的综合证据.
主要成果:
- CHD1作为瘤抑制剂起作用,并在前列腺癌中影响神经内分泌分化.
- 失去CHD1与侵袭性疾病,治疗耐药性和PTEN损失的合成致死性有关.
- CHD1影响乳腺癌,卵巢癌和血液癌的染色质可访问性,转录和耐治疗性.
结论:
- 根据背景,CHD1在癌症中表现出复杂的双重作用,既起抑制作用,又起促进作用.
- 作为生物标志物和治疗标,CHD1具有前景,但其双重功能带来了挑战.
- 进一步的研究对于阐明CHD1与免疫路径的相互作用及其在治疗耐药性和非前列腺癌中的作用至关重要.
更多相关视频
相关概念视频
Epigenetic Regulation
2.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
2.9K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer
47.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.1K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Spreading of Chromatin Modifications
8.1K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.1K


